Clark AJ. The mammary gland as a bioreactor：expression, processing, and production of recombinant proteins[J]. J Mammary Gland Biol Neoplasia, 1998, 3（3）, 337-350.
[2]
Houdebine LM. Use of transgenic animals to improve human health and animal production[J]. Reprod Dom Anim, 2005, 40：269-281.
[3]
B?sze Z, Baranyi M, Whitelaw CB. Producing recombinant human milk proteins in the milk of livestock species[J]. Adv Exp Med Biol, 2008, 606：357-393.
[4]
Kitagawa H, Hayashi T, Mitsumoto Y, et al. Reduction of ischemic brain injury by topical application of glial cell line-derived neurotrophic factor after permanent middle cerebral artery occlusion in rats[J]. Stroke, 1998, 29（7）：1417-1422.
[5]
Li L, Wu W, Lin LF, et al. Rescue of adult mouse motoneurons from injury-induced cell death by glial cell line-derived neurotrophic factor[J]. Proc Natl Acad Sci USA, 1995, 92：9771-9775.
[6]
Kim BT, Rao VL, Sailor KA, et al. Protective effects of glial cell line-derived neurotrophic factor on hippocampal neurons after traumatic brain injury in rats[J]. J Neurosurg, 2001, 95：674-679.
[7]
Tomac A, Lindqvist E, Lin LF, et al. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo[J]Nature, 1995, 373：335-339.
[8]
Gash DM, Zhang Z, Ovadia A, et al. Functional recovery in parkinsonian monkeys treated with GDNF[J]. Nature, 1996, 380：252-255.
[9]
Gill SS, Patel NK, Hotton GR, et al. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease[J]. Nat Med, 2003, 9：589-595.
[10]
Love S, Plaha P, Patel NK, et al. Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain[J]. Nat Med, 2005, 11：703-704.
[11]
Patel NK, Bunnage M, Plaha P, et al. Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD：a two-year outcome study[J]. Ann Neurol, 2005, 57：298-302.
[12]
Slevin JT, Gerhardt GA, Smith CD, et al. Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor[J]. J Neurosurg, 2005, 102：216-222.
[13]
Patel NK, Pavese N, Javed S, et al. Benefits of putaminal GDNF infusion in Parkinson disease are maintained after GDNF cessation[J]. Neurology, 2013, 81：1176-1178.
Yan XR, Yang YH, Liu W, et al. Differentiation of neuron-like cells from mouse parthenogenetic embryonic stem cells[J]. Neural Regeneration Research, 2013（4）：293-300.
[18]
Wilmut I, Schnieke AE, McWhir J, et al. Viable offspring derived from fetal and adult mammalian cells[J]. Nature, 1997, 385（6619）：810-813.
[19]
Denning C and Priddle H. New frontiers in gene targeting and cloning：success, application and challenges in domestic animals and human embryonic stem cells[J]. Reproduction, 2003, 126：1-11.
[20]
Schnieke AE, Kind AJ, Ritchie WA, et al. Human factor IX transgenic sheep produced by transfer of nuclei from transfected fetal fibroblasts[J]. Science, 1997, 278（5346）：21.
[21]
McCreath KJ, Howcroft J, Campbell KHS, et al. Production of gene targeting sheep by nuclear transfer from cultured somatic cells[J]. Nature, 2000, 405：1066-1069.
[22]
Baguisi A, Behboodi E, Melican DT, et al. Production of goats by somatic cell nuclear transfer[J]. Nat Biotechnol, 1999, 17（5）：456-461.
[23]
Lai L, Kolber-Simonds D, Park KW, et al. Production of a-1, 3-galactosyl transferase knockout pigs by nuclear transfer cloning[J]. Science, 2002, 295：1089-1092.
[24]
Wells DN, Misica PM, McMillan WH, et al. Production of cloned bovine fetuses following nuclear transfer using cells from a fetal fibroblast cell line[J]. Theriogenology, 1998, 49：330.
[25]
Kuroiwa Y, Kasinathan P, Matsushita H, et al. Sequential targeting of the genes encoding immunoglobulinm and prion protein in cattle[J]. Nat Genet, 2004, 36：775-780.
[26]
Chen SH, Vaught TD, Monahan JA, et al. Efficient production of transgenic cloned calves using preimplantation screening[J]. Biol Reprod, 2002, 67：1488-1492.
